Oriental Precision & Engineering Co.,Ltd. (KOSDAQ:014940)
6,550.00
+220.00 (3.48%)
At close: May 21, 2026
KOSDAQ:014940 Revenue
In the year 2025, Oriental Precision & Engineering had annual revenue of 207.26B KRW, down -0.02%. Oriental Precision & Engineering had revenue of 51.86B in the quarter ending December 31, 2025, a decrease of -8.72%.
Revenue
207.26B
Revenue Growth
-0.02%
P/S Ratio
1.40
Revenue / Employee
843.88M
Employees
252
Market Cap
298.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 207.26B | -49.52M | -0.02% |
| Dec 31, 2024 | 207.31B | 49.77B | 31.60% |
| Dec 31, 2023 | 157.53B | 25.96B | 19.73% |
| Dec 31, 2022 | 131.57B | 15.65B | 13.50% |
| Dec 31, 2021 | 115.92B | -51.82B | -30.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CJ Freshway | 3.48T |
| Sammok S-Form Co.,Ltd | 316.99B |
| Ace Technologies | 178.43B |
| BINEX | 168.47B |
| NeoPharm CO., LTD. | 132.18B |
| Selvas AI | 114.78B |
| Humedix | 110.99B |
| EMRO., Incorporated. | 83.98B |